首页> 外国专利> CONDENSED HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND ITS PHARMACEUTICAL APPLICATION

CONDENSED HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND ITS PHARMACEUTICAL APPLICATION

机译:包含相同成分的稠合杂环衍生物,药物组合物及其药物应用

摘要

PPROBLEM TO BE SOLVED: To provide a condensed heterocyclic derivative developing excellent human SGLT activity-inhibiting action and useful as a prophylactic or therapeutic agent for diseases caused by hyperglycemia, e.g. diabetes mellitus, hyperglycemia after eating, impaired glucose tolerance, diabetic complication and obesity. PSOLUTION: The present invention provides a compound represented by formula (1) [wherein RSP1/SPis H, a halogen, OH or the like; RSP2/SPis H, a halogen or an alkyl; R3 and R4 are each H, OH, a halogen or the like; Q is an alkylene or the like; the ring A is an aryl or a heteroaryl; G is a group represented by formula (G1) or formula (G2)], its pharmacologically acceptable salt and their prodrugs. Further, excellent human SGLT-1 and/or -2 activity inhibitor can be produced by including the compound as an active ingredient. PCOPYRIGHT: (C)2005,JPO&NCIPI
机译:<要解决的问题:提供一种稠合的杂环衍生物,其开发出优异的人SGLT活性抑制作用,并可用作预防或治疗高血糖症所致疾病的药物。糖尿病,进食后高血糖,糖耐量受损,糖尿病并发症和肥胖。

解决方案:本发明提供了由式(1)表示的化合物[其中RSP> 1为H,卤素,OH等; R 2 是H,卤素或烷基; R3和R4分别为H,OH,卤素等; Q为亚烷基等。环A为芳基或杂芳基; G是由式(G1)或式(G2)],其药理学上可接受的盐及其前药表示的基团。此外,通过包含该化合物作为活性成分,可以制备优异的人SGLT-1和/或-2活性抑制剂。

版权:(C)2005,JPO&NCIPI

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号